Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Malka

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
ESMO Gastrointestinal Oncology|February 6, 2026
Codon-specific <i>KRAS</i> mutations predict survival in advanced pancreatic cancerA Boilève, A Rousseau, M Hilmi, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
ESMO Open|November 3, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF<sup>V600</sup>-mutated melanomaJ Y Blay, C Cropet, S Mansard, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
ESMO Gastrointestinal Oncology|February 6, 2026
Codon-specific <i>KRAS</i> mutations predict survival in advanced pancreatic cancerA Boilève, A Rousseau, M Hilmi, et al.
Digestive Diseases and Sciences|October 31, 2022
The Frequency of Germline BRCA and Non-BRCA HR-Gene-Variants in a Cohort of Pancreatic Cancer PatientsM Baz, V Gondran-Teiller, B Bressac, et al.
ESMO Open|November 3, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF<sup>V600</sup>-mutated melanomaJ Y Blay, C Cropet, S Mansard, et al.
Pageof 6